GEMCAP logo

GEMCAP

A phase III multicentre randomised clinical trial comparing gemcitabine alone or in combination with capecitabine for the treatment of patients with advanced pancreatic cancer.

GEMCAP

A phase III multicentre randomised clinical trial comparing gemcitabine alone or in combination with capecitabine for the treatment of patients with advanced pancreatic cancer.
Funding
Portfolio Cancer
Interventions Medicine
Randomised Yes
Status Closed
Start Date 01-Jan-0001

Pancreatic cancer represents one of the most important oncological challenges. This is reflected in the poor overall one-year survival of around 10% and long-term survival of only 0.4% 1. It is one of the top ten causes of cancer death in the Western world and is responsible for 6,000 deaths per year in the UK and around 40,000 per year in Europe 2,3